Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 251 entries
View as:

A Trial to Evaluate the Efficacy, Safety, and Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-deficit/Hyperactivity Disorder

Phase: N/A Priority: Normal
NCT ID: NCT03605836 Org: User:
Start: 01/16/19 End: 05/14/20 Due: 05/14/21

A Multiple Dose Safety, Tolerability and Pharmacokinetics Study in Adult Patients With Schizophrenia Following Administration of Aripiprazole IM Depot

Phase: N/A Priority: Normal
NCT ID: NCT01870999 Org: User:
Start: 11/30/07 End: 10/31/08 Due: 10/31/09

Tolvaptan Extension Study in Participants With ADPKD

Phase: N/A Priority: Normal
NCT ID: NCT01214421 Org: User:
Start: 05/26/10 End: 02/29/16 Due: 02/28/17

Brexpiprazole in Treatment of Children and Adolescents With Irritability Associated With Autism Spectrum Disorder for Subjects That Have Completed Participation in 331-201-00148

Phase: N/A Priority: Normal
NCT ID: NCT04258839 Org: User:
Start: 01/23/20 End: 03/16/23 Due: 03/16/24

A Study of Aripiprazole in the Management of Patients With Schizophrenia in the General Psychiatric Practices

Phase: N/A Priority: Normal
NCT ID: NCT00237939 Org: User:
Start: 09/30/02 End: 11/30/06 Due: 11/30/07

Drug-drug Interaction Study of Aripiprazole and Lamotrigine in Patients With Bipolar Type I Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00321516 Org: User:
Start: 07/31/06 End: 02/28/07 Due: 02/28/08

Tolvaptan Open-label Pilot Efficacy, Tolerability, and Safety Study in Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Phase: N/A Priority: Normal
NCT ID: NCT00413777 Org: User:
Start: 12/31/05 End: 06/30/10 Due: 06/30/11

FACTS I: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT00064441 Org: User:
Start: 05/31/03 End: 05/31/06 Due: 05/31/07

A Trial of Centanafadine Efficacy and Safety in Adolescents With Attention- Deficit/Hyperactivity Disorder

Phase: N/A Priority: Normal
NCT ID: NCT05257265 Org: User:
Start: 02/02/22 End: 10/05/23 Due: 10/05/24

Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type

Phase: N/A Priority: Normal
NCT ID: NCT00036114 Org: User:
Start: 03/31/00 End: 08/31/03 Due: 08/31/04

An Extension Study of Safety and Tolerability of SEP-363856 in Adult Subjects With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT02970929 Org: User:
Start: 01/31/17 End: 01/29/19 Due: 01/29/20

Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.

Phase: N/A Priority: Normal
NCT ID: NCT01122927 Org: User:
Start: 07/31/10 End: 09/30/14 Due: 09/30/15

Trial to Evaluate the Long-term Efficacy of Oral Aripiprazole in the Treatment of Pediatric Participants With Tourette's Disorder

Phase: N/A Priority: Normal
NCT ID: NCT03661983 Org: User:
Start: 10/13/18 End: 06/30/20 Due: 06/30/21

A Clinical Study That Will Assess How Food Moves Through the Stomach and Effects Blood Glucose Levels in Subjects With Schizophrenia Taking SEP-363856 or and Prior Antipsychotic (PA) Standard

Phase: N/A Priority: Normal
NCT ID: NCT05402111 Org: User:
Start: 06/13/22 End: 09/27/23 Due: 09/27/24

Efficacy, Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Phase: N/A Priority: Normal
NCT ID: NCT02442765 Org: User:
Start: 07/23/15 End: 02/27/19 Due: 02/27/20

A Trial in Adult Participants With Schizophrenia Treated Prospectively for 6-months With Abilify MyCite®

Phase: N/A Priority: Normal
NCT ID: NCT03892889 Org: User:
Start: 04/29/19 End: 09/29/20 Due: 09/29/21

Study of Aripiprazole in the Treatment of Serious Behavioral Problems in Children and Adolescents With Autistic Disorder (AD)

Phase: N/A Priority: Normal
NCT ID: NCT00365859 Org: User:
Start: 09/30/06 End: 06/30/09 Due: 06/30/10

Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT01683058 Org: User:
Start: 01/31/13 End: 02/28/14 Due: 02/28/15

Study of Three Doses of Aripiprazole in Patients With Acute Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00080327 Org: User:
Start: 11/30/03 End: 09/30/04 Due: 09/30/05

Open-label Study to Evaluate the Effectiveness of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01710709 Org: User:
Start: 11/30/12 End: 12/31/16 Due: 12/31/17

Aripiprazole Pharmacokinetics (PK) and Tolerability Study in Children and Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT00102479 Org: User:
Start: 07/31/04 End: 07/31/05 Due: 07/31/06

Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00706654 Org: User:
Start: 09/30/08 End: 08/31/12 Due: 08/31/13

Observational Study in Patients With Autosomal Dominant Polycystic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT01430494 Org: User:
Start: 06/30/11 End: 10/31/14 Due: 10/31/15

A Single-blind, Placebo-controlled, Outpatient Trial to Assess the Effects of Single Oral Tablet Dose of OPC-214870

Phase: N/A Priority: Normal
NCT ID: NCT04241965 Org: User:
Start: 02/18/20 End: 10/28/21 Due: 10/28/22

Study of Aripiprazole in Patients With Acute Bipolar Mania

Phase: N/A Priority: Normal
NCT ID: NCT00097266 Org: User:
Start: 12/31/04 End: 01/31/07 Due: 01/31/08